The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
The extent of last winter's floods has been revealed after a survey by the Local Government Association
Jackie Walker, vice-chair of the pro-Corbyn group Momentum, was suspended over comments shown on a leaked video.
Britain's biggest auto company Jaguar Land Rover said some European customers are turning their noses up at UK-made vehicles.